| Phase 2 |
| NCT07281456 |
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease |
Sjogren's Syndrome |
Recruiting |
2026-10-02 |
| NCT03571191 |
Denosumab Treatment for Fibrous Dysplasia |
Bone Diseases |
Active, Not Recruiting |
2022-02-18 |
| Phase 1/2 |
| NCT07541209 |
Safety and Efficacy of PTH-IA |
Jansen's Metaphyseal Chondrodysplasia |
Recruiting |
2026-10-01 |
| NCT04496960 |
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome |
Sjogren's Syndrome |
Active, Not Recruiting |
2025-12-18 |
| Phase 1 |
| NCT00804154 |
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer |
Intractable Pain |
Recruiting |
2026-08-31 |
| Not specified |
| NCT00001727 |
Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and the… |
McCune-Albright Syndrome |
Recruiting |
2026-10-13 |
| NCT00024804 |
A Natural History Study of Bone and Mineral Disorders |
Tumor Induced Osteomalcia |
Recruiting |
2026-10-13 |
| NCT01425892 |
The Pathogenesis and Natural History of Sjogren's Disease |
Sjogren's Syndrome |
Recruiting |
2026-10-13 |
| NCT01568697 |
Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis) |
Immunosuppression |
Recruiting |
2026-10-13 |
| NCT02327884 |
Characterization of Diseases With Salivary Gland Involvement |
Healthy Volunteer |
Recruiting |
2026-10-08 |
| NCT02639312 |
Natural History of Craniofacial Anomalies and Developmental Growth Variants |
Prognathism |
Recruiting |
2026-10-01 |
| NCT01805869 |
Oral Specimen and Data Acquisition Study of Subjects Requiring Third Molar Removal |
Stomatognatic |
Recruiting |
2026-09-30 |